Background: Hashimoto thyroiditis (HT) is uncommon in infancy, and myxedema coma (MC) is even less common. While prior reports have documented these entities separately, to our knowledge, MC in combination with HT has not been reported before in this age group. Methods/Results: A 10-month-old female presented with ptosis, lethargy, dysphagia, and failure to thrive (FTT). She developed hypotension, bradycardia, hypothermia, and apnea requiring intubation. Initial thyroid-stimulating hormone was 422 μIU/mL, and free thyroxine was < 0.5 ng/dL, despite the presence of a normal thyroid newborn screen (NBS). Of note, sepsis workup was unremarkable. With the diagnosis of MC, treatment with intravenous levothyroxine was initiated, although after hydrocortisone administration to avert the possibility of an adrenal crisis, despite a random cortisol of 16.4 μg/dL. Based on positive thyroid antibodies suggesting HT, autoimmune workup later revealed positive acetylcholinesterase antibodies consistent with a diagnosis of ocular myasthenia gravis. Conclusion: MC may be a cause of altered mental status in infancy and may simultaneously be associated with FTT on presentation. With the presence of a normal thyroid NBS, autoimmunity should be entertained as the etiology of profound hypothyroidism, as positive thyroid antibodies may prompt an exploration for coexisting diseases which may explain other presenting features.

1.
Hampton
J
.
Thyroid gland disorder emergencies: thyroid storm and myxedema coma
.
AACN Adv Crit Care
.
2013
Jul-Sep
;
24
(
3
):
325
32
.
[PubMed]
1559-7768
2.
Mathew
V
,
Misgar
RA
,
Ghosh
S
,
Mukhopadhyay
P
,
Roychowdhury
P
,
Pandit
K
, et al.
Myxedema coma: a new look into an old crisis
.
J Thyroid Res
.
2011
;
2011
:
493462
.
[PubMed]
2042-0072
3.
Cappa
M
,
Bizzarri
C
,
Crea
F
.
Autoimmune thyroid diseases in children
.
J Thyroid Res
.
2010
Dec
;
2011
:
675703
.
[PubMed]
2042-0072
4.
Zhu
Y
,
Qiu
W
,
Deng
M
,
Zhu
X
.
Myxedema coma: A case report of pediatric emergency care
.
Medicine (Baltimore)
.
2017
May
;
96
(
21
):
e6952
.
[PubMed]
0025-7974
5.
Thompson
MD
,
Henry
RK
.
Myxedema Coma Secondary to Central Hypothyroidism: A Rare but Real Cause of Altered Mental Status in Pediatrics
.
Horm Res Paediatr
.
2017
;
87
(
5
):
350
3
.
[PubMed]
1663-2818
6.
Root
JM
,
Vargas
M
,
Garibaldi
LR
,
Saladino
RA
.
Pediatric Patient With Altered Mental Status and Hypoxemia: case Report
.
Pediatr Emerg Care
.
2017
Jul
;
33
(
7
):
486
8
.
[PubMed]
0749-5161
7.
Schutt-Aine
JC
.
Hypothyroid myxedema and hyponatremia in an eight-year-old child: a case report
.
J Natl Med Assoc
.
1980
Jul
;
72
(
7
):
705
8
.
[PubMed]
0027-9684
8.
Bühler
UK
,
Savary
A
,
Krauer
B
,
Stalder
GR
.
Water intoxication in a cretinoid infant
.
J Clin Endocrinol Metab
.
1966
Jan
;
26
(
1
):
111
6
.
[PubMed]
0021-972X
9.
Wartofsky
L
.
Myxedema coma
.
[vii-viii.]
.
Endocrinol Metab Clin North Am
.
2006
Dec
;
35
(
4
):
687
98
.
[PubMed]
0889-8529
10.
Popoveniuc
G
,
Chandra
T
,
Sud
A
,
Sharma
M
,
Blackman
MR
,
Burman
KD
, et al.
A diagnostic scoring system for myxedema coma
.
Endocr Pract
.
2014
Aug
;
20
(
8
):
808
17
.
[PubMed]
1530-891X
11.
Chiong
YV
,
Bammerlin
E
,
Mariash
CN
.
Development of an objective tool for the diagnosis of myxedema coma
.
Transl Res
.
2015
Sep
;
166
(
3
):
233
43
.
[PubMed]
1931-5244
12.
Mills
L
,
Lim
S
.
Identifying and treating thyroid storm and myxedema coma in the emergency department
.
Emerg Med Pract
.
2009
;
11
(
8
):
1
26
.1524-1971
13.
Sanaker
PS
,
Husebye
ES
,
Fondenes
O
,
Bindoff
LA
.
Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure
.
Acta Neurol Scand Suppl
.
2007
;
187
s187
:
64
7
.
[PubMed]
0065-1427
14.
Kahaly
GJ
.
Polyglandular autoimmune syndromes
.
Eur J Endocrinol
.
2009
Jul
;
161
(
1
):
11
20
.
[PubMed]
0804-4643
15.
Amerio
P
,
Tracanna
M
,
De Remigis
P
,
Betterle
C
,
Vianale
L
,
Marra
ME
, et al.
Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4
.
Clin Exp Dermatol
.
2006
Sep
;
31
(
5
):
746
9
.
[PubMed]
0307-6938
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.